{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:30:19Z","timestamp":1790573419967,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jneuroim.2011.01.012","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T14:16:02Z","timestamp":1299507362000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Beh\u00e7et's Disease"],"prefix":"10.1016","volume":"233","author":[{"given":"Kamel","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Borhani Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imed Ben","family":"Ghorbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Houman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.01.012_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","article-title":"Interleukin-6 in neuro-Beh\u00e7et's disease: association with disease subsets and long-term outcome","volume":"44","author":"Akman-Demir","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management","volume":"8","author":"Al-Arij","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0015","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.0900621106","article-title":"Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t","volume":"106","author":"Ayyoub","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10067-009-1279-8","article-title":"Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Beh\u00e7et's disease","volume":"29","author":"Bilginer","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jns.2008.01.017","article-title":"Comment on \u201chistopathology of central nervous system lesions in Behcet's disease\u201d","volume":"270","author":"Borhani Haghighi","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/ern.09.11","article-title":"Treatment of Neuro-Beh\u00e7et's disease: an update","volume":"9","author":"Borhani Haghighi","year":"2009","journal-title":"Exp. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Beh\u00e7et's disease","volume":"111","author":"Borhani Haghighi","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0040","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/ar2608","article-title":"Distinct synovial immunopathology in Beh\u00e7et disease and psoriatic arthritis","volume":"11","author":"Ca\u00f1ete","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0045","first-page":"880","article-title":"Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A","volume":"16","author":"Chi","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0050","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.4049\/jimmunol.0803646","article-title":"Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner","volume":"182","author":"Collison","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","article-title":"Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD","volume":"35","author":"Dalghous","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1beta and IL-2 convert human Treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin. Immunol."},{"issue":"215","key":"10.1016\/j.jneuroim.2011.01.012_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2009.07.010","article-title":"Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?","volume":"2009","author":"Drulovic","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0080","first-page":"1","article-title":"Transcriptional characteristics of CD4+ T cells in multiple Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive population in blood","volume":"16","author":"Edstr\u00f6m","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0085","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2010.114","article-title":"IL-17A has an important role in the acute attacks of Beh\u00e7et's disease","volume":"130","author":"Ekinci","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0090","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.0708426104","article-title":"Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes","volume":"104","author":"Evans","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2006.02.011","article-title":"Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Beh\u00e7et's disease","volume":"175","author":"Hamzaoui","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jneuroim.2007.04.020","article-title":"Regulatory T cells in cerebrospinal fluid from Beh\u00e7et's disease with neurological manifestations","volume":"187","author":"Hamzaoui","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0115","first-page":"S52","article-title":"Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Beh\u00e7et's disease","volume":"27","author":"Hamzaoui","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2009.05.005","article-title":"VEGF and mRNA VEGF expression in CSF from Beh\u00e7et's disease with neurological involvement","volume":"213","author":"Hamzaoui","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0125","first-page":"1","article-title":"The international classification of headache disorders, second edition","volume":"24","author":"Headache classification subcommittee of the international headache society","year":"2004","journal-title":"Cephalgia"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et's syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/0-306-48382-3_28","article-title":"Risk factors of neuro-Beh\u00e7et","volume":"528","author":"Houman","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0140","first-page":"78","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0145","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","article-title":"IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NFkappaB signaling pathways","volume":"173","author":"Kao","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0150","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Beh\u00e7et's disease","volume":"20","author":"Kim","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0155","first-page":"S20","article-title":"Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Beh\u00e7et's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature","volume":"23","author":"K\u00f6tter","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(00)00397-X","article-title":"Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Beh\u00e7et's disease","volume":"179","author":"Niino","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(00)80671-8","article-title":"Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism","volume":"9","author":"Ouyang","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et's disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s002510000212","article-title":"Tbt-1, a new T-box transcription factor induced in activated Th1 and CD8+ T cells","volume":"51","author":"Shier","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells","volume":"14","author":"Stromnes","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0190","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1167\/iovs.10-5286","article-title":"Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Beh\u00e7et's patients with uveitis: a new activity marker?","volume":"51","author":"Usui","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3","volume":"8","author":"Williams","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0200","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/eji.200838145","article-title":"Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and ROR gamma t","volume":"38","author":"Yang","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2011.01.012_bb0210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:09Z","timestamp":1759047489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0165572811000233"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.01.012","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Beh\u00e7et's Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}